Phenotypic tolerance: Antibiotic enrichment of noninherited resistance in bacterial populations

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1483-1494

  Wiuff, C ^a   Zappala, R M ^a   Regoes, R R ^a   Garner, K N ^a   Baquero, F ^b   Levin, B R ^a  

^a EMORY UNIVERSITY   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM MUTANT; COLONY FORMING UNIT; CONTROLLED STUDY; CROSS TOLERANCE; DRUG CROSS TOLERANCE; DRUG EFFICACY; ESCHERICHIA COLI; MATHEMATICAL MODEL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PHENOTYPIC TOLERANCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; COMPUTER SIMULATION; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; DRUG TOLERANCE; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 16244399491     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1483-1494.2005     Document Type: Article

References (39)

1. Balaban, N. Q., J. Merrin, R. Chait, L. Kowalik, and S. Leibler. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
2. Barclay, M. L., and E. J. Begg. 2001. Aminoglycoside adaptive resistance: importance for effective dosage regimens. Drugs 61:713-721.
3. Barclay, M. L., E. J. Begg, and S. T. Chambers. 1992. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob. Agents Chemother. 36:1951-1957.
4. Bloch, C. A., and C. K. Rode. 1996. Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12. Infect. Immun. 64:3218-3223.
5. Bloch, C. A., G. M. Thorne, and F. M. Ausubel. 1989. General method for site-directed mutagenesis in Escherichia coli O18ac:K1:H7: deletion of the inducible superoxide dismutase gene, sodA, does not diminish bacteremia in neonatal rats. Infect. Immun. 57:2141-2148.
6. Bull, J. J., B. R. Levin, T. DeRouin, N. Walker, and C. A. Bloch. 2002. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2:35. [Online.] http://www.biomedcentral.com/1471- 2180/2/35.
7. Carret, G., J. P. Flandrois, and J. R. Lobry. 1991. Biphasic kinetics of bacterial killing by quinolones. J. Antimicrob. Chemother. 27:319-327.
8. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
9. Craig, W. A., and S. C. Ebert. 1990. Killing and regrowth of bacteria in vitro: a review. Scand. J. Infect. Dis. Suppl. 74:63-70.
10. Daikos, G. L., G. G. Jackson, V. T. Lolans, and D. M. Livermore. 1990. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J. Infect. Dis. 162:414-420.
11. Daikos, G. L., V. T. Lolans, and G. G. Jackson. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35:117-123.
12. Delacher, S., H. Derendorf, U. Hollenstein, M. Brunner, C. Joukhadar, S. Hofmann, A. Georgopoulos, H. G. Eichler, and M. Muller. 2000. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J. Antimicrob. Chemother. 46:733-739.
13. Diver, J. M., and R. Wise. 1986. Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. J. Antimicrob. Chemother. 18(Suppl. D):31-41.
14. Elowitz, M. B., A. J. Levine, E. D. Siggia, and P. S. Swain. 2002. Stochastic gene expression in a single cell. Science 297:1183-1186.
15. Firsov, A. A., S. N. Vostrov, O. V. Kononenko, S. H. Zinner, and Y. A. Portnoy. 1999. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 43:498-502.
16. Firsov, A. A., S. N. Vostrov, A. A. Shevchenko, S. H. Zinner, G. Cornaglia, and Y. A. Portnoy. 1998. MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model. Antimicrob. Agents Chemother. 42:2848-2852.
17. Fung-Tomc, J. C., E. Gradelski, L. Valera, B. Kolek, and D. P. Bonner. 2000. Comparative killing rates of fluoroquinolones and cell wall-active agents. Antimicrob. Agents Chemother. 44:1377-1380.
18. Guerillot, F., G. Garret, and J. P. Flandrois. 1993. Mathematical model for comparison of time-killing curves. Antimicrob. Agents Chemother. 37:1685-1689.
19. Kaldalu, N., R. Mei, and K. Lewis. 2004. Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob. Agents Chemother. 48:890-896.
20. Karlowsky, J. A., M. H. Saunders, G. A. Harding, D. J. Hoban, and G. G. Zhanel. 1996. In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:1387-1393.
21. Keren, I., N. Kaldalu, A. Spoering, Y. Wang, and K. Lewis. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
22. Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
23. Korobkova, E., T. Emonet, J. M. Vilar, T. S. Shimizu, and P. Cluzel. 2004. From molecular noise to behavioural variability in a single bacterium. Nature 428:574-578.
24. Libby, J. M. 1998. Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring. Antimicrob. Agents Chemother. 42:78-82.
25. Lipsitch, M., and B. R. Levin. 1997. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41:363-373.
26. Lorian, V., J. Ernst, and L. Amaral. 1989. The postantibiotic effect defined by bacterial morphology. J. Antimicrob. Chemother. 23:485-491.
27. MacGowan, A. P., M. Wootton, A. J. Hedges, K. E. Bowker, H. A. Holt, and D. S. Reeves. 1996. A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone. J. Antimicrob. Chemother. 38:193-203.
28. Miller, C., L. E. Thomsen, C. Gaggero, R. Mosseri, H. Ingmer, and S. N. Cohen. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631.
29. Mueller, M., A. De La Pena, and H. Derendorf. 2004. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrob. Agents Chemother. 48:369-377.
30. Regoes, R. R., C. Wiuff, R. M. Zappala, K. N. Garner, F. Baquero, and B. R. Levin. 2004. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob. Agents Chemother. 48:3670-3676.
31. Schiemann, D. A. 1995. An unstable small-colony variant of a noninvasive mutant of Salmonella typhimurium is highly invasive for MDCK cells. FEMS Microbiol. Lett. 130:45-49.
32. Tuomanen, E. 1986. Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. Rev. Infect. Dis. 8(Suppl. 3):S279-S291.
33. Tuomanen, E., R. Cozens, W. Tosch, O. Zak, and A. Tomasz. 1986. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol. 132:1297-1304.
34. Tuomanen, E., D. T. Durack, and A. Tomasz. 1986. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30:521-527.
35. Tuomanen, E., J. Schwartz, and S. Sande. 1990. The vir locus affects the response of Bordetella pertussis to antibiotics: phenotypic tolerance and control of autolysis. J. Infect. Dis. 162:560-563.
36. Tuomanen, E., and A. Tomasz. 1990. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. Scand. J. Infect. Dis. Suppl. 74:102-112.
37. von Eiff, C., C. Heilmann, R. A. Proctor, C. Woltz, G. Peters, and F. Gotz. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4705-4712.
38. Weiser, J. N., Z. Markiewicz, E. I. Tuomanen, and J. H. Wani. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect. Immun. 64:2240-2245.
39. Xiong, Y. Q., J. Caillon, M. F. Kergueris, H. Drugeon, D. Baron, G. Potel, and A. S. Bayer. 1997. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob. Agents Chemother. 41:823-826.